The pursuit of novel therapeutic agents often involves targeting specific enzymatic pathways to modulate biological processes. Malonyl-CoA decarboxylase (MCD) is an enzyme that plays a critical role in fatty acid metabolism, and its inhibition has shown promise in treating conditions such as obesity, type 2 diabetes, and metabolic syndrome. The development of potent and selective MCD inhibitors relies heavily on sophisticated organic synthesis, and here, compounds like 1-(4-aminophenyl)-2,2,2-trifluoroethanone (CAS: 23516-79-2) prove invaluable.
As a trifluoroacetophenone derivative, 1-(4-aminophenyl)-2,2,2-trifluoroethanone offers a unique structural scaffold that can be modified to create molecules with high affinity and specificity for the MCD enzyme. The trifluoromethyl group can influence lipophilicity and metabolic stability, while the amino-phenyl moiety provides a site for further derivatization, allowing medicinal chemists to fine-tune the pharmacological properties of the resulting inhibitors. Researchers often look to buy this compound as a starting point for their drug discovery efforts.
The research and development phase for such specialized compounds necessitates a reliable supply of high-purity intermediates. Pharmaceutical R&D departments and contract research organizations (CROs) frequently source CAS 23516-79-2 from reputable chemical manufacturers. When procuring these critical materials, it is essential to ensure the manufacturer can provide a consistent product with minimal impurities. This guarantees the reproducibility of experimental results and the integrity of the synthesized drug candidates.
For those involved in the synthesis of potential MCD inhibitors, identifying a trusted manufacturer and supplier for 1-(4-aminophenyl)-2,2,2-trifluoroethanone is a key strategic decision. Companies that specialize in fluorinated intermediates and offer competitive pricing, especially from manufacturing hubs like China, are often preferred. The availability of free samples for initial validation and the assurance of timely delivery for ongoing projects are significant factors. By partnering with reliable suppliers, researchers can accelerate their progress in developing next-generation therapeutics targeting metabolic disorders.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.